The majority of carcinosarcomas harbor a TP53 mutation or have abnormal (mutant pattern) p53 immunostaining in the absence of a pathogenic polymerase epsilon catalytic subunit (POLE) mutation and mismatch repair deficiency (MMRd) and thus belong to the p53abn molecular subtype3,7,8. Here, TP53 is linked to carcinosarcoma.